Table 1.

Clinical characteristics of progressing and non-progressing patients

	Progressed		Non-progressed
Gender	M (68%)		M (69%)
BINET/RAI stage at diagnosis	A0 (72%)		A0 (92%)
IGHV Status	UM (56%)		UM (8%)
	Median	Range	Median	Range
Age at diagnosis	63	40–82	66	47–81
TTP (months)	29	5–96	–	–
Follow-up without progression (months)	–	–	77	41–101
Time to second sampling (months)	29	5–96	39	30–77
Lymphocytes·109/L at diagnosis	12.20	3.3-65.8	10.40	3.8-31.2
Lymphocytes·109/L at second sampling	73.05	2.3-287.1	22.40	5.2-85.3